Home >> Industry News >> Cobas 5800 molecular Dx system launched in CE markets

Cobas 5800 molecular Dx system launched in CE markets

image_pdfCreate PDF

The Cobas 5800 system will offer the same menu as the Cobas 6800 and 8800 systems, including the Cobas SARS-CoV-2 test. The system offers an expanded onboard capacity allowing labs to test multiple assays simultaneously and delivers up to 144 results in an eight-hour shift.

Roche anticipates receiving FDA approval during the third quarter of 2022.

CAP TODAY
X